Modulation of experimental autoimmune encephalomyelitis: Effect of altered peptide ligand on chemokine and chemokine receptor expression

Journal of Neuroimmunology

Volumn 110, Issue 1-2, 2000, Pages 195-208

  Fischer, Falko R ^a   Santambrogio, Laura ^a   Luo, Yi ^a   Berman, Michael A ^a   Hancock, Wayne W ^b   Dorf, Martin E ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MILLENNIUM PHARMACEUTICALS INC   (United States)

Author keywords

Altered peptide ligand; Chemokine; Chemokine receptor; Experimental autoimmune encephalomyelitis; Th1 Th2

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR3; FRACTALKINE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEOLIPID PROTEIN; RANTES;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; DEMYELINATING DISEASE; DNA POLYMORPHISM; FEMALE; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPINAL CORD; TH1 CELL; TH2 CELL;

ANIMAL; CHEMOKINES; CHEMOKINES, CXC; DNA, ANTISENSE; ENCEPHALOMYELITIS, EXPERIMENTAL AUTOIMMUNE; FEMALE; GENE EXPRESSION; LIGANDS; MACROPHAGE INFLAMMATORY PROTEIN-1; MEMBRANE PROTEINS; MICE; MICE, INBRED STRAINS; MONOCYTE CHEMOATTRACTANT PROTEIN-1; MYELIN PROTEOLIPID PROTEIN; PEPTIDE FRAGMENTS; POLYMORPHISM (GENETICS); RANTES; RECEPTORS, CCR5; RECEPTORS, CHEMOKINE; RECEPTORS, INTERLEUKIN-8B; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TH1 CELLS;

EID: 0034597050     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(00)00351-9     Document Type: Article

References (58)

1. Baggiolini M. Chemokines and leukocyte traffic. Nature. 392:1998;565-568.
2. Balashov K.B., Rottman J.B., Weiner H.L., Hancock W.W. CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions. Proc. Natl. Acad. Sci. USA. 96:1999;6873-6878.
3. Berman J.W., Guida M.P., Warren J., Amat J., Brosnan C.F. Localization of monocyte chemoattractant peptide-1 expression in the central nervous system in experimental autoimmune encephalomyelitis and trauma in the rat. J. Immunol. 156:1996;3017-3023.
4. Bonecchi R., Bianchi G., Bordignon P.P., D'ambrosio D., Lang R., Borsatti A., et al. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J. Exp. Med. 187:1998;129-134.
5. Brocke S., Gijbels K., Allegretta M., Ferber I., Piercy C., Blankenstein T., et al. Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein. Nature. 379:1996;343-346.
6. Brosnan C.F., Raine C.S. Mechanisms of immune injury in multiple sclerosis. Brain Pathol. 6:1996;243-257.
7. Brown A., McFarlin D.B., Raine C.S. Chronologic neuropathology of relapsing experimental allergic encephalomyelitis in the mouse. Lab. Invest. 46:1982;171-185.
8. Campbell J.J., Haraldsen G., Pan J., Rottman J., Qin S., Ponath P., et al. The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells. Nature. 400:1999;776-780.
9. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
10. Cross A.H., Raine C.S. Central nervous system endothelial polymorphonuclear cell interactions during autoimmune demyelination. Am. J. Pathol. 139:1991;1401-1409.
11. D'Ambrosio D., lellem A., Bonecchi R., Mazzeo D., Sozzani S., Mantovani A., et al. Selective up-regulation of chemokine receptors CCR4 and CCR8 upon activation of polarized human type 2 Th cells. J. Immunol. 161:1998;5111-5115.
12. Ebnet K., Kaldjian E.P., Anderson A.O., Shaw S. Orchestrated information transfer underlying leukocyte endothelial interactions. Annu. Rev. Immunol. 14:1996;155-177.
13. Evavold B.D., Allen P.M. Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand. Science. 252:1991;1308-1310.
14. Glabinski A.R., Tani M., Tuohy V.K., Tuthill R.J., Ransohoff R.M. Central nervous system chemokine mRNA accumulation follows initial leukocyte entry at the onset of acute murine experimental autoimmune encephalomyelitis. Brain Behav. Immun. 9:1995;315-330.
15. Godiska R., Chantry D., Dietsch G.N., Gray P.W. Chemokine expression in murine experimental allergic encephalomyelitis. J. Neuroimmunol. 58:1995;167-176.
16. Grimaldi J.C., Yu N.X., Grunig G., Seymour B.W., Cottrez F., Robinson D.S., et al. Depletion of eosinophils in mice through the use of antibodies specific for C-C chemokine receptor 3 (CCR3). J. Leukoc. Biol. 65:1999;846-853.
17. Gu L., Tseng S., Homer R.M., Tam C., Loda M., Rollins B.J. Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1. Nature. 404:2000;407-411.
18. Hallensleben W., Biro L., Sauder C., Hausmann J., Asensio V.C., Campbell I.L., et al. A polymorphism in the mouse crg-2/IP-10 gene complicates chemokine gene expression analysis using a commercial ribonuclease protection assay. J. Immunol. Methods. 234:2000;149-151.
19. Hancock W.W., Polanski M., Zhang J., Blogg N., Weiner H.L. Suppression of insulitis in non-obese diabetic (NOD) mice by oral insulin administration is associated with selective expression of interleukin-4 and -10, transforming growth factor-beta, and prostaglandin-E. Am. J. Pathol. 147:1995;1193-1199.
20. Hulkower K., Brosnan C.F., Aquino D.A., Cammer W., Kulshrestha S., Guida M.P., et al. Expression of CSF-1, c-fms, and MCP-1 in the central nervous system of rats with experimental allergic encephalomyelitis. J. Immunol. 150:1993;2525-2533.
21. Karpus W.J., Kennedy K.J. MIP-1alpha and MCP-1 differentially regulate acute and relapsing autoimmune encephalomyelitis as well as Thl/Th2 lymphocyte differentiation. J. Leukoc. Biol. 62:1997;681-687.
22. Karpus W.J., Lukacs N.W., Kennedy K.J., Smith W.S., Hurst S.D., Barrett T.A. Differential CC chemokine-induced enhancement of T helper cell cytokine production. J. Immunol. 158:1997;4129-4136.
23. Karpus W.J., Lukacs N.W., McRae B.L., Strieter R.M., Kunkel S.L., Miller S.D. An important role for the chemokine macrophage inflammatory protein-1 alpha in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis. J. Immunol. 155:1995;5003-5010.
24. Karpus W.J., Ransohoff R.M. Chemokine regulation of experimental autoimmune encephalomyelitis: temporal and spatial expression patterns govern disease pathogenesis. J. Immunol. 161:1998;2667-2671.
25. Kawai T., Seki M., Hiromatsu K., Eastcott J.W., Watts G.F., Sugai M., et al. Selective diapedesis of Th1 cells induced by endothelial cell RANTES. J. Immunol. 163:1999;3269-3278.
26. Kuchroo V.K., Greer J.M., Kaul D., Ishioka G., Franco A., Sette A., et al. A single TCR antagonist peptide inhibits experimental allergic encephalomyelitis mediated by a diverse T cell repertoire. J. Immunol. 153:1994;3326-3336.
27. Kuchroo V.K., Martin C.A., Greer J.M., Ju S.T., Sobel R.A., Dorf M.B. Cytokines and adhesion molecules contribute to the ability of myelin proteolipid protein-specific T cell clones to mediate experimental allergic encephalomyelitis. J. Immunol. 151:1993;4371-4382.
28. Loetscher P., Uguccioni M., Bordoli L., Baggiolini M., Moser B., Chizzolini C., et al. CCR5 is characteristic of Th1 lymphocytes. Nature. 391:1998;344-345.
29. Luster A.D. Chemokines - chemotactic cytokines that mediate inflammation. N. Engl. J. Med. 338:1998;436-445.
30. Ma Q., Jones D., Borghesani P.R., Segal R.A., Nagasawa T., Kishimoto T., et al. Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice. Proc. Natl. Acad. Sci. USA. 95:1998;9448-9453.
31. Matejuk A., Vandenbark A.A., Burrows G.G., Bebo B.F. Jr., Offner H. Reduced chemokine and chemokine receptor expression in spinal cords of TCR BV852 transgenic mice protected against experimental autoimmune encephalomyelitis with BV852 protein. J. Immunol. 164:2000;3924-3931.
32. McColl S.R., Staykova M.A., Wozniak A., Fordham S., Bruce J., Willenborg D.O. Treatment with anti-granulocyte antibodies inhibits the effector phase of experimental autoimmune encephalomyelitis. J. Immunol. 161:1998;6421-6426.
33. Middleton J., Neil S., Wintle J., Clark-Lewis I., Moore H., Lam C., et al. Transcytosis and surface presentation of IL-8 by venular endothelial cells. Cell. 91:1997;385-395.
34. Mosmann T.R., Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol. Today. 17:1996;138-146.
35. Murphy P.M. The molecular biology of leukocyte chemoattractant receptors. Annu. Rev. Immunol. 12:1994;593-633.
36. Nicholson L.B., Greer J.M., Sobel R.A., Lees M.B., Kuchroo V.K. An altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis. Immunity. 3:1995;397-405.
37. Nicholson L.B., Kuchroo V.K. T cell recognition of self and altered self antigens. Crit. Rev. Immunol. 17:1997;449-462.
38. Qin S., Rottman J.B., Myers P., Kassam N., Weinblatt M., Loetscher M., et al. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J. Clin. Invest. 101:1998;746-754.
39. Raine C.S., Barnett L.B., Brown A., Behar T., McFarlin D.E. Neuropathology of experimental allergic encephalomyelitis in inbred strains of mice. Lab. Invest. 43:1980;150-157.
40. Rajan A.J., Asensio V.C., Campbell I.L., Brosnan C.F. Experimental autoimmune encephalomyelitis on the SJL mouse: effect of gamma delta T cell depletion on chemokine and chemokine receptor expression in the central nervous system. J. Immunol. 164:2000;2120-2130.
41. Randolph D.A., Huang G., Carruthers C.J., Bromley L.E., Chaplin D.D. The role of CCR7 in TH1 and TH2 cell localization and delivery of B cell help in vivo. Science. 286:1999;2159-2162.
42. Ransohoff R.M., Hamilton T.A., Tani M., Stoler M.H., Shick H.E., Major J.A., et al. Astrocyte expression of mRNA encoding cytokines IP-10 and JE/MCP-1 in experimental autoimmune encephalomyelitis. FASEB J. 7:1993;592-600.
43. Ruiz P.J., Garren H., Hirschberg D.L., Langer-Gould A.M., Levite M., Karpuj M.V., et al. Microbial epitopes act as altered peptide ligands to prevent experimental autoimmune encephalomyelitis. J. Exp. Med. 189:1999;1275-1284.
44. Sakai K., Zamvil S.S., Mitchell D.J., Hodgkinson S., Rothbard J.B., Steinman L. Prevention of experimental encephalomyelitis with peptides that block interaction of T cells with major histocompatibility complex proteins. Proc. Natl. Acad. Sci. USA. 86:1989;9470-9474.
45. Sallusto F., Lenig D., Mackay C.R., Lanzavecchia A. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J. Exp. Med. 187:1998;875-883.
46. Sallusto F., Mackay C.R., Lanzavecchia A. Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science. 277:1997;2005-2007.
47. Santambrogio L., Lees M.B., Sobel R.A. Altered peptide ligand modulation of experimental allergic encephalomyelitis: immune responses within the CNS. J. Neuroimmunol. 81:1998;1-13.
48. Siveke J.T., Hamann A. T helper 1 and T helper 2 cells respond differentially to chemokines. J. Immunol. 160:1998;550-554.
49. Sloan-Lancaster J., Allen P.M. Significance of T-cell stimulation by altered peptide ligands in T cell biology. Curr. Opin. Immunol. 7:1995;103-109.
50. Smilek D.E., Wraith D.C., Hodgkinson S., Dwivedy S., Steinman L., McDevitt H.O. A single amino acid change in a myelin basic protein peptide confers the capacity to prevent rather than induce experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. USA. 88:1991;9633-9637.
51. Sorensen T.L., Tani M., Jensen J., Pierce V., Lucchinetti C., Folcik V.A., et al. Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. J. Clin. Invest. 103:1999;807-815.
52. Soto H., Wang W., Strieter R.M., Copeland N.G., Gilbert D.J., Jenkins N.A., et al. The CC chemokine 6Ckine binds the CXC chemokine receptor CXCR3. Proc. Natl. Acad. Sci. USA. 95:1998;8205-8210.
53. Stein J.V., Rot A., Luo Y., Narasimhaswamy M., Nakano H., Gunn M.D., et al. The CC chemokine thymus-derived chemotactic agent 4 (TCA-4, secondary lymphoid tissue chemokine, 6Ckine, exodus-2) triggers lymphocyte function-associated antigen 1-mediated arrest of rolling T lymphocytes in peripheral lymph node high endothelial venules. J. Exp. Med. 191:2000;61-76.
54. Tanabe S., Heesen M., Yoshizawa I., Berman M.A., Luo Y., Bleul C.C., et al. Functional expression of the CXC-chemokine receptor-4/fusin on mouse microglial cells and astrocytes. J. Immunol. 159:1997;905-911.
55. Tanaka Y., Adams D.H., Hubscher S., Hirano H., Siebenlist U., Shaw S. T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-1 beta. Nature. 361:1993;79-82.
56. Zamvil S.S., Steinman L. The T lymphocyte in experimental allergic encephalomyelitis. Annu. Rev. Immunol. 8:1990;579-621.
57. Zingoni A., Soto H., Hedrick J.A., Stoppacciaro A., Storlazzi C.T., Sinigaglia F., et al. The chemokine receptor CCR8 is preferentially expressed in Th2 but not Th1 cells. J. Immunol. 161:1998;547-551.
58. Zlotnik A., Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity. 12:2000;121-127.